David Isaac Finkelstein (Kevin J Barnham, David I Finkelstein)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

Biomedicines

The Journal of biological chemistry

PLoS pathogens

Acta neuropathologica communications

Florey Institute of Neuroscience and Mental Health

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Florey Institute of Neuroscience and Mental Health Jan 01 2011

Australia

Head Parkinson's Disease Laboratory :: The University of Melbourne

Publications

Katie K N Tran, Vickie H Y Wong, Kirstan A Vessey, David Isaac Finkelstein, Bang V Bui, Christine T O Nguyen
Levodopa Rescues Retinal Function in the Transgenic A53T Alpha-Synuclein Model of Parkinson's Disease. Biomedicines 12 (1) (2024)
Katie K N Tran, Vickie H Y Wong, Kirstan A Vessey, David Isaac Finkelstein, Bang V Bui, Christine T O Nguyen
Levodopa Rescues Retinal Function in the Transgenic A53T Alpha-Synuclein Model of Parkinson's Disease. Biomedicines 12 (1) (2024)
Samantha Bramich, Alastair J Noyce, Anna E King, Sharon L Naismith, Maneesh Varghese Kuruvilla, Simon J G Lewis, Edward Hill, Aidan D Bindoff, David Isaac Finkelstein, Leah C Beauchamp, James C Vickers, Laura Pérez-Carbonell, Jane E Alty
Isolated rapid eye movement sleep behaviour disorder (iRBD) in the Island Study Linking Ageing and Neurodegenerative Disease (ISLAND) Sleep Study: protocol and baseline characteristics. Journal of sleep research (2023)
Tracy D Zhang, Scott C Kolbe, Leah C Beauchamp, Ella K Woodbridge, David Isaac Finkelstein, Emma L Burrows
How Well Do Rodent Models of Parkinson's Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review. Biomedicines 10 (12) (2022)
Ali Esfandiary, David Isaac Finkelstein, Nicolas Hans Voelcker, David Rudd
Clinical Sphingolipids Pathway in Parkinson's Disease: From GCase to Integrated-Biomarker Discovery. Cells 11 (8) (2022)
Tracy D Zhang, Scott C Kolbe, Leah C Beauchamp, Ella K Woodbridge, David Isaac Finkelstein, Emma L Burrows
How Well Do Rodent Models of Parkinson's Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review. Biomedicines 10 (12) (2022)
David Isaac Finkelstein, Jessica L Billings, Paul A Adlard, Scott Ayton, Amelia Sedjahtera, Colin L Masters, Simon Wilkins, David M Shackleford, Susan A Charman, Wojciech Bal, Izabela A Zawisza, Ewa Kurowska, Andrew L Gundlach, Sheri Ma, Ashley I Bush, Dominic J Hare, Philip A Doble, Simon Crawford, Elisabeth C L Gautier, Jack Parsons, Penny Huggins, Kevin J Barnham, Robert A Cherny
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. Acta neuropathologica communications 9 (1) (2021)
Ali Shahandeh, Bang V Bui, David Isaac Finkelstein, Christine T O Nguyen
Therapeutic applications of chelating drugs in iron metabolic disorders of the brain and retina. Journal of neuroscience research 98 (10) (2020)
Stephanie J Guiney, Paul A Adlard, Peng Lei, Celeste H Mawal, Ashley I Bush, David Isaac Finkelstein, Scott Ayton
Fibrillar α-synuclein toxicity depends on functional lysosomes. The Journal of biological chemistry (2020)
Cathryn L Ugalde, Shane E Gordon, Mitch Shambrook, Amirmohammad Nasiri Kenari, Bradley M Coleman, Matthew A Perugini, Victoria A Lawson, David Isaac Finkelstein, Andrew F Hill
An intact membrane is essential for small extracellular vesicle-induced modulation of α-synuclein fibrillization. Journal of extracellular vesicles 10 (2) (2020)
Jessica L Billings, Sarah L Gordon, Tristan Rawling, Philip A Doble, Ashley I Bush, Paul A Adlard, David Isaac Finkelstein, Dominic James Hare
l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease. Journal of neurochemistry 150 (1) (2019)
Simote Totauhelotu Foliaki, Victoria Lewis, Abu Mohammed Taufiqual Islam, Laura Jane Ellett, Matteo Senesi, David Isaac Finkelstein, Blaine Roberts, Victoria A Lawson, Paul Anthony Adlard, Steven John Collins
Early existence and biochemical evolution characterise acutely synaptotoxic PrPSc. PLoS pathogens 15 (4) (2019)
Cathryn L Ugalde, Victoria A Lawson, David Isaac Finkelstein, Andrew F Hill
The role of lipids in α-synuclein misfolding and neurotoxicity. The Journal of biological chemistry 294 (23) (2019)
Simote Totauhelotu Foliaki, Victoria Lewis, David Isaac Finkelstein, Victoria A Lawson, Harold Arthur Coleman, Matteo Senesi, Abu Mohammed Taufiqual Islam, Feng Chen, Shannon Sarros, Blaine Roberts, Paul Anthony Adlard, Steven John Collins
Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species. PLoS pathogens 14 (8) (2018)
David Isaac Finkelstein, Jessica L Billings, Paul A Adlard, Scott Ayton, Amelia Sedjahtera, Colin L Masters, Simon Wilkins, David M Shackleford, Susan A Charman, Wojciech Bal, Izabela A Zawisza, Ewa Kurowska, Andrew L Gundlach, Sheri Ma, Ashley I Bush, Dominic J Hare, Philip A Doble, Simon Crawford, Elisabeth Cl Gautier, Jack Parsons, Penny Huggins, Kevin J Barnham, Robert A Cherny
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. Acta neuropathologica communications 5 (1) (2017)

David Isaac Finkelstein.css-eqlu8i{font-size:small;padding-left:4px;} (Kevin J Barnham, David I Finkelstein)

Publication Activity (10 Years)

Top Topics

Top Venues

David Isaac Finkelstein (Kevin J Barnham, David I Finkelstein)